Form 4 for ZNTL Zentalis Pharmaceuticals, Inc.
Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-06 · accession 0001725160-21-000235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-07 | 2021-12-06 | ZNTL | Gallagher Cam | Dir | S - Sale | $71.33 | -10.0K | 427.2K | -2% | -$713.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-06 | S | D | 10,000 | $71.33 | 427,203 | D | — | — |